Regular review: Tumour markers in malignancies
- 12 February 2000
- Vol. 320 (7232) , 424-427
- https://doi.org/10.1136/bmj.320.7232.424
Abstract
Methods This article is based largely on our experience, discussions with colleagues, reviews, and original articles on the subject, as well as on a textbook on chromosomal rearrangement in tumour cells. We used the following key words for Medline searches for 1966-98: cancer, tumour markers, prognosis, various malignant diseases, and RT-PCR [reversed transcriptase and polymerase chain reaction].Keywords
This publication has 33 references indexed in Scilit:
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyNew England Journal of Medicine, 1998
- Micrometastases and Survival in Stage II Colorectal CancerNew England Journal of Medicine, 1998
- PSA screening said to reduce prostate-cancer deaths, or does it?The Lancet, 1998
- PSA for outcome prediction and posttreatment evaluation following radiation for prostate cancer: Do we know how to use it?Seminars in Radiation Oncology, 1998
- SYT–SSXGene Fusion as a Determinant of Morphology and Prognosis in Synovial SarcomaNew England Journal of Medicine, 1998
- The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumourNature Genetics, 1997
- Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986‐91Acta Paediatrica, 1997
- Detection of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma using the reverse transcriptase-polymerase chain reactionGenes, Chromosomes and Cancer, 1996
- Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reactionThe Lancet, 1991
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989